Companies › LFMD

LIFEMD (LFMD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000948320 · EDGAR filings · Updated 2026-07-08

LIFEMD (LFMD) has reported institutional ownership of 37.2%, with 102 institutional managers holding positions valued at $64.4M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-08 — SCHEDULE 13G filed
• 2026-06-22 — Current report (8-K) filed
• 2026-06-03 — Insider transaction reported (Form 4)
• 2026-06-03 — Initial insider ownership filed (Form 3)
• 2026-05-13 — Insider transaction reported (Form 4)
• 2026-05-06 — Quarterly report (10-Q) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LIFEMD has 102 institutional holders and institutional ownership of 37.2%.

Insider activity

Insiders reported 38 transactions (0 buys, 12 sells) across 14 reporting insiders, with a net reported value of −$4.89M.

Data flags from SEC filings

Related companies

AC IMMUNE SA (ACIU) · LEONABIO INC (LONA) · Unicycive Therapeutics Inc (UNCY) · HUTCHMED CHINA LTD (HCM) · Achieve Life Sciences Inc (ACHV) · ALDEYRA THERAPEUTICS INC (ALDX)